AVITA Medical Inc

AVH: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|T$$?$dLOCK|R<LLOCK|<>W>v!g

Avita Medical Earnings: Profitability in Sight With Continued Progress in Cash Efficiency

Avita's 2025 results came in line with market expectations, with revenue up 11%, meeting guidance. Reiterated 2026 guidance implies an acceleration of revenue growth to 15% at the midpoint. Fourth-quarter 2025 cash burn fell to USD 5 million from USD 6 million in the third quarter.

Sponsor Center